Skip to content

Clinical Efficacy of Supratrochlear Artery Perforator Flap for Repair of Nasal Tumor Defects: A Retrospective Study

Clinical Efficacy of Supratrochlear Artery Perforator Flap for Repair of Nasal Tumor Defects: A Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110809
Enrollment
Unknown
Registered
2025-10-21
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin tumours

Interventions

Case series:None

Sponsors

Hospital for skin diseases, Institute of dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years; 2. Diagnosed with cutaneous tumours (including benign and malignant tumours such as basal cell carcinoma, squamous cell carcinoma, lymphoma, Bowen's disease, seborrheic keratosis) via histopathological examination by the hospital's pathology department; 3. Patients underwent excision of the lesion and repair of the defects with STAP at our hospital; 4. Patients with at least 6 months of follow-up and complete clinical records.

Exclusion criteria

Exclusion criteria: 1. Patients lost to follow-up; 2. Patients with less than 6 months of follow-up or incomplete clinical records; 3. Patients with pre-existing nasal deformities (e.g., congenital nasal deformities, post-traumatic nasal deformities) or prior nasal surgery.

Design outcomes

Primary

MeasureTime frame
Global Aesthetic Improvement Scale (GAIS);

Secondary

MeasureTime frame
Vancouver Scar Scale (VSS);Flap survival rate;Tumor recurrence;Patient Satisfaction Assessment;

Countries

China

Contacts

Public ContactBu wenbo

Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College

buwenbo@163.com+86 150 0515 7051

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026